H.R. 1, or the Big Beautiful Bill, has brought substantial change to the managed care pharmacy landscape, particularly for managed care organizations (MCOs) with managed Medicaid lines of business.
The Academy of Managed Care Pharmacy (AMCP) supports an abbreviated licensure pathway for the approval of biosimilar biologic drug therapies.
Academy of Managed Care Pharmacy (AMCP) has been recognized as a Power of Associations Silver Award by the American Society of Association Executives (ASAE) for its successful Health Disparities in Medication Use and Access Awareness initiative.
HealthyWomen, members of its HPV Coalition and additional stakeholders are writing the Advisory Committee on Immunization Practices (ACIP) regarding the upcoming June ACIP meeting June 25-27, 2025, docket number - CDC-2005-0024.
Today, Senator Josh Hawley (R-MO) introduced legislation that would rollback some of the impending cuts to federal Medicaid funding as mandated by H.R. 1.
AMCP held a Precision Medicine Partnership Forum to examine solutions to challenges of access, consistency, and quality in precision oncology.
The Department of Health and Human Services (HHS) sent out an RFI. AMCP provided a response which aims to promote precision medicine through a reconsideration of the "14 Day Rule".
Findings published in JMCP for a 3-phase AMCP Market Insights program on Food Allergies that included a national survey of managed care professionals, in-depth interviews with managed care experts, and a moderated virtual roundtable discussion including clinical and managed care experts.
On July 4, President Trump signed H.R. 1, often referred to as the One Big Beautiful Bill Act, into law.
Key insights from the discussion related to supporting patient needs in MS, advancing understanding of MS, emerging treatments in MS, using real-world evidence in MS coverage decision-making, and addressing continued challenges in MS. Suggested payer best practices in MS also emerged from the discussion.
